COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32689703.
- Also identified by DOI 10.1016/j.jtcvs.2020.03.061 and PMC identifier 7146695.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The extraordinary demands of managing the COVID-19 pandemic has disrupted the world's ability to care for patients with thoracic malignancies. As a hospital's COVID-19 population increases and hospital resources are depleted, the ability to provide surgical care is progressively restricted, forcing surgeons to prioritize among their cancer populations. Representatives from multiple cancer, surgical, and research organizations have come together to provide a guide for triaging patients with thoracic malignancies as the impact of COVID-19 evolves as each hospital.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Delivery of Health Care, Integrated
- Pneumonia, Viral
- Thoracic Neoplasms
- Thoracic Surgical Procedures
- Triage